CTHM Grd Rds: Updates from IWCLL meeting 9/15: Moving to non-chemotherapy induction therapy for CLL-D. Rizzieri, MD |
10/06/2015 - 12:00pm to 1:00pm EDT |
CTHM Grand Rounds-unraveling the proteasome inhibitor resistance in multiple myeloma-M. Baljevic, MD |
10/13/2015 - 12:00pm to 1:00pm EDT |
CTHM Grand Rds-extracellular vesicles and glioblastoma multiform; thrombosis in the context of MDS-N. Papadantonakis, MD, MSc, PhD |
11/03/2015 - 12:00pm to 1:00pm EST |
CT&HM Grand Rounds - HLA Nomenclature_Current Challenges - A. DeOliveira, BS, CHS, MS |
04/12/2016 - 8:00am to 9:00am EDT |
CT and HM Grand Rounds - Medical Response to Radiation Exposure: the Role of Hematologists- N. Chao |
06/28/2016 - 8:00am to 9:00am EDT |
CT and HM Grand Rds - SIV Pro00064227: A phase 1 trial of Fostamatinib and GVHD Development after Allo SCT - S. Anand, MD |
01/12/2016 - 8:00am to 9:00am EST |
CT & HM Grand Rounds - Extracorporeal Photopheresis (ECP) for GVHD: Deciding when,....-R. Lopez, MD |
05/10/2016 - 8:00am to 9:00am EDT |
CT & HM Gr Rds - 1. APP Skills Day: Improving Compliance and Standardizing Care and 2. Myeloma - 1. K Minor and 2. C Gasparetto |
02/02/2016 - 8:00am to 9:00am EST |
Cellular Therapy and Hematologic Malignancies Grand Rounds: Open Patient Note - Kath Pollak, Ph.D. |
02/09/2016 - 8:00am to 9:00am EST |
Cellular Therapy and Hematologic Malignancies Grand Rounds-HCT immunization guideline update - J. Saullo, MD, Pharm.D. |
11/10/2015 - 12:00pm to 1:00pm EST |